A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter

Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy. With the ongoing large-scale vaccination in different countries and continuous surge of new variants of global concerns, a convenient, cost-effe...

Full description

Saved in:
Bibliographic Details
Published inEmerging microbes & infections Vol. 10; no. 1; pp. 894 - 904
Main Authors Tsai, Wen-Yang, Ching, Lauren L., Hsieh, Szu-Chia, Melish, Marian E., Nerurkar, Vivek R., Wang, Wei-Kung
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.01.2021
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy. With the ongoing large-scale vaccination in different countries and continuous surge of new variants of global concerns, a convenient, cost-effective and high-throughput neutralization test is urgently needed. Conventional SARS-CoV-2 neutralization test is tedious, time-consuming and requires a biosafety level 3 laboratory. Despite recent reports of neutralizations using different pseudoviruses with a luciferase or green fluorescent protein reporter, the laborious steps, inter-assay variability or high background limit their high-throughput potential. In this study we generated lentivirus-based pseudoviruses containing a monomeric infrared fluorescent protein reporter to develop neutralization assays. Similar tropism, infection kinetics and mechanism of entry through receptor-mediated endocytosis were found in the three pseudoviruses generated. Compared with pseudovirus D614, pseudovirus with D614G mutation had decreased shedding and higher density of S1 protein present on particles. The 50% neutralization titers to pseudoviruses D614 or D614G correlated with the plaque reduction neutralization titers to live SARS-CoV-2. The turn-around time of 48-72 h, minimal autofluorescence, one-step image quantification, expandable to 384-well, sequential readouts and dual quantifications by flow cytometry support its high-throughput and versatile applications at a non-reference and biosafety level 2 laboratory, in particular for assessing the neutralization sensitivity of new variants by sera from natural infection or different vaccinations during our fight against the pandemic.
AbstractList Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy. With the ongoing large-scale vaccination in different countries and continuous surge of new variants of global concerns, a convenient, cost-effective and high-throughput neutralization test is urgently needed. Conventional SARS-CoV-2 neutralization test is tedious, time-consuming and requires a biosafety level 3 laboratory. Despite recent reports of neutralizations using different pseudoviruses with a luciferase or green fluorescent protein reporter, the laborious steps, inter-assay variability or high background limit their high-throughput potential. In this study we generated lentivirus-based pseudoviruses containing a monomeric infrared fluorescent protein reporter to develop neutralization assays. Similar tropism, infection kinetics and mechanism of entry through receptor-mediated endocytosis were found in the three pseudoviruses generated. Compared with pseudovirus D614, pseudovirus with D614G mutation had decreased shedding and higher density of S1 protein present on particles. The 50% neutralization titers to pseudoviruses D614 or D614G correlated with the plaque reduction neutralization titers to live SARS-CoV-2. The turn-around time of 48-72 h, minimal autofluorescence, one-step image quantification, expandable to 384-well, sequential readouts and dual quantifications by flow cytometry support its high-throughput and versatile applications at a non-reference and biosafety level 2 laboratory, in particular for assessing the neutralization sensitivity of new variants by sera from natural infection or different vaccinations during our fight against the pandemic.
Author Tsai, Wen-Yang
Nerurkar, Vivek R.
Hsieh, Szu-Chia
Wang, Wei-Kung
Ching, Lauren L.
Melish, Marian E.
Author_xml – sequence: 1
  givenname: Wen-Yang
  surname: Tsai
  fullname: Tsai, Wen-Yang
  organization: John A. Burns School of Medicine, University of Hawaii at Manoa
– sequence: 2
  givenname: Lauren L.
  surname: Ching
  fullname: Ching, Lauren L.
  organization: John A. Burns School of Medicine, University of Hawaii at Manoa
– sequence: 3
  givenname: Szu-Chia
  surname: Hsieh
  fullname: Hsieh, Szu-Chia
  organization: John A. Burns School of Medicine, University of Hawaii at Manoa
– sequence: 4
  givenname: Marian E.
  surname: Melish
  fullname: Melish, Marian E.
  organization: John A. Burns School of Medicine
– sequence: 5
  givenname: Vivek R.
  surname: Nerurkar
  fullname: Nerurkar, Vivek R.
  organization: John A. Burns School of Medicine, University of Hawaii at Manoa
– sequence: 6
  givenname: Wei-Kung
  orcidid: 0000-0002-6670-4663
  surname: Wang
  fullname: Wang, Wei-Kung
  email: wangwk@hawaii.edu
  organization: John A. Burns School of Medicine, University of Hawaii at Manoa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33929934$$D View this record in MEDLINE/PubMed
BookMark eNp9Udtu1DAQjVARLaWfAPIPZLFj5-IXxGpFoVIlJAq8Wl5fEleJHY2dVuUv-sc4bFu1L8yDLzPnnLHnvC2OfPCmKN4TvCG4wx-rHKStyabCFdkQXtWkoa-KkzVfroWjZ-fj4izGa5yjxQ0j7E1xTCmvOKfspLjfIjByLJObDJJeo8H1Q5kGCEs_zEtC3iwJ5Oj-yOSCR8nEhPYyGo3y7Wr746rchd9lheZoFh1uHCwRqeCTdN75Hk3Bh8mAU8h5CxIyz45LABOV8QnNEJJxHsmYnzEHSAbeFa-tHKM5e9hPi1_nX37uvpWX379e7LaXpaopS2VLuDUWVzVrlG40by3dW8aM7Borm4Yyxg3lWGHNG07ySlSGWia1wpx1mp4WFwddHeS1mMFNEu5EkE78SwTohYTk1GhEHnZnLaGdsZwxpmUnCaOEUtzajnGStT4dtOZlPxm9fi3P7IXoy4p3g-jDjeiyTlPVWaA-CCgIMYKxT1yCxWq5eLRcrJaLB8sz78Pzxk-sR4Mz4PMBkMcfYJK3AUYtkrwbA2Q_vHJR0P_3-AsOw7-4
CitedBy_id crossref_primary_10_4110_in_2021_21_e39
crossref_primary_10_1007_s00216_021_03806_6
crossref_primary_10_3389_fmed_2022_1019490
crossref_primary_10_1016_j_ijid_2023_11_036
crossref_primary_10_1111_sji_13088
crossref_primary_10_1016_j_vaccine_2022_01_021
crossref_primary_10_1128_spectrum_04081_22
crossref_primary_10_3390_v14102087
crossref_primary_10_1016_j_jcv_2022_105185
Cites_doi 10.1038/s41467-020-15562-9
10.1038/s41586-020-2571-7
10.1126/science.abc6284
10.1038/s41587-020-0631-z
10.1016/j.molcel.2020.04.022
10.1056/NEJMoa2001017
10.1016/S1387-2656(05)11007-2
10.3390/v12050513
10.1371/journal.pone.0045851
10.21769/BioProtoc.2940
10.1080/22221751.2019.1682948
10.1073/pnas.77.7.3884
10.1038/s41586-020-2012-7
10.1016/j.cell.2020.06.043
10.1016/j.virol.2007.06.026
10.1016/j.cell.2020.06.025
10.1016/j.cell.2020.02.058
10.1016/j.chom.2020.11.012
10.1084/jem.20201181
10.1038/s41467-020-19808-4
10.1038/nbt.1918
10.1093/infdis/jiaa673
10.1007/s00259-008-0870-6
10.4161/cc.26985
10.1038/nmeth.2521
10.1038/s41591-021-01255-3
10.1073/pnas.0809524106
10.1006/viro.1995.1016
10.1016/j.celrep.2020.03.002
10.1038/s41467-019-13897-6
10.1038/s41586-020-03041-6
10.1126/science.abf2946
10.1073/pnas.2003138117
10.1128/JVI.00556-18
10.1038/s41586-020-2548-6
10.1074/jbc.M114.610428
10.1126/science.abb2507
10.1073/pnas.0306446101
10.1038/s41423-020-00605-4
10.1016/j.cell.2020.12.015
10.1016/j.antiviral.2020.104742
10.1128/JCM.02107-20
ContentType Journal Article
Copyright 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021
2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s)
Copyright_xml – notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021
– notice: 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s)
DBID 0YH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOA
DOI 10.1080/22221751.2021.1925163
DatabaseName Taylor & Francis Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
DocumentTitleAlternate Emerging Microbes & Infections
EISSN 2222-1751
EndPage 904
ExternalDocumentID oai_doaj_org_article_2218ff138ef9444da8a14313307f8491
10_1080_22221751_2021_1925163
33929934
1925163
Genre Coronaviruses
Journal Article
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: P30 GM114737
– fundername: NIAID NIH HHS
  grantid: R01 AI149502
– fundername: NINR NIH HHS
  grantid: R01 NR004569
– fundername: NIAID NIH HHS
  grantid: R21 AI135292
GroupedDBID 0YH
3V.
53G
5VS
7X7
8FI
ACGFS
ADBBV
ADRAZ
AENEX
AFKRA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BENPR
BPHCQ
BVXVI
DIK
EBS
ECGQY
EMOBN
FYUFA
GROUPED_DOAJ
HYE
KQ8
M1P
M48
M4Z
M~E
NAO
OK1
PIMPY
PQEST
PQQKQ
PQUKI
PROAC
RNT
RNTTT
RPM
UKHRP
88E
8FJ
AAHBH
ABUWG
ACSMW
AJTQC
ALIPV
BCNDV
C6C
CCPQU
CGR
CUY
CVF
ECM
EIF
EJD
HMCUK
NPM
PSQYO
TDBHL
AAYXX
CITATION
5PM
ID FETCH-LOGICAL-c534t-719fef02546cd6d97f3bf44ea86fa663449e390c0d96910d91c546f4adc0948d3
IEDL.DBID RPM
ISSN 2222-1751
IngestDate Tue Oct 22 15:01:13 EDT 2024
Tue Sep 17 20:40:05 EDT 2024
Fri Aug 23 03:27:17 EDT 2024
Sat Nov 02 12:28:12 EDT 2024
Tue Jul 04 18:17:09 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords monomeric infrared fluorescent protein
pseudovirus
SARS-CoV-2
reporter
neutralization
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c534t-719fef02546cd6d97f3bf44ea86fa663449e390c0d96910d91c546f4adc0948d3
Notes Supplemental data for this article can be accessed https://doi.org/10.1080/22221751.2021.1925163
ORCID 0000-0002-6670-4663
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143625/
PMID 33929934
PageCount 11
ParticipantIDs crossref_primary_10_1080_22221751_2021_1925163
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8143625
informaworld_taylorfrancis_310_1080_22221751_2021_1925163
pubmed_primary_33929934
doaj_primary_oai_doaj_org_article_2218ff138ef9444da8a14313307f8491
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Emerging microbes & infections
PublicationTitleAlternate Emerg Microbes Infect
PublicationYear 2021
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References CIT0030
CIT0010
CIT0032
CIT0031
CIT0012
CIT0034
CIT0011
CIT0033
V'kovski P (CIT0004) 2020; 28
CIT0014
CIT0036
CIT0013
CIT0035
CIT0016
CIT0038
CIT0015
CIT0037
CIT0018
CIT0017
CIT0039
CIT0019
CIT0041
CIT0021
CIT0043
CIT0020
CIT0042
CIT0001
CIT0023
CIT0045
CIT0022
CIT0044
CIT0003
CIT0025
CIT0047
CIT0002
CIT0024
CIT0046
CIT0005
CIT0027
CIT0026
CIT0007
CIT0029
CIT0006
CIT0028
CIT0009
Herrera BB (CIT0040) 2018; 9
CIT0008
References_xml – ident: CIT0014
  doi: 10.1038/s41467-020-15562-9
– ident: CIT0044
  doi: 10.1038/s41586-020-2571-7
– ident: CIT0025
  doi: 10.1126/science.abc6284
– ident: CIT0042
  doi: 10.1038/s41587-020-0631-z
– ident: CIT0009
  doi: 10.1016/j.molcel.2020.04.022
– ident: CIT0002
  doi: 10.1056/NEJMoa2001017
– ident: CIT0019
  doi: 10.1016/S1387-2656(05)11007-2
– ident: CIT0013
  doi: 10.3390/v12050513
– ident: CIT0041
  doi: 10.1371/journal.pone.0045851
– ident: CIT0020
  doi: 10.21769/BioProtoc.2940
– ident: CIT0023
  doi: 10.1080/22221751.2019.1682948
– ident: CIT0034
  doi: 10.1073/pnas.77.7.3884
– ident: CIT0001
  doi: 10.1038/s41586-020-2012-7
– ident: CIT0029
– ident: CIT0011
  doi: 10.1016/j.cell.2020.06.043
– ident: CIT0033
  doi: 10.1016/j.virol.2007.06.026
– ident: CIT0043
  doi: 10.1016/j.cell.2020.06.025
– ident: CIT0006
  doi: 10.1016/j.cell.2020.02.058
– ident: CIT0047
  doi: 10.1016/j.chom.2020.11.012
– volume: 9
  start-page: e00755
  year: 2018
  ident: CIT0040
  publication-title: mBio
  contributor:
    fullname: Herrera BB
– ident: CIT0015
  doi: 10.1084/jem.20201181
– ident: CIT0016
  doi: 10.1038/s41467-020-19808-4
– ident: CIT0021
  doi: 10.1038/nbt.1918
– ident: CIT0039
  doi: 10.1093/infdis/jiaa673
– ident: CIT0017
  doi: 10.1007/s00259-008-0870-6
– ident: CIT0012
– ident: CIT0018
  doi: 10.4161/cc.26985
– ident: CIT0022
  doi: 10.1038/nmeth.2521
– ident: CIT0031
  doi: 10.1038/s41591-021-01255-3
– ident: CIT0007
  doi: 10.1073/pnas.0809524106
– ident: CIT0032
  doi: 10.1006/viro.1995.1016
– ident: CIT0035
  doi: 10.1016/j.celrep.2020.03.002
– ident: CIT0003
– ident: CIT0024
  doi: 10.1038/s41467-019-13897-6
– volume: 28
  start-page: 1
  year: 2020
  ident: CIT0004
  publication-title: Nat Rev Microbiol
  contributor:
    fullname: V'kovski P
– ident: CIT0026
  doi: 10.1038/s41586-020-03041-6
– ident: CIT0030
  doi: 10.1126/science.abf2946
– ident: CIT0010
  doi: 10.1073/pnas.2003138117
– ident: CIT0038
  doi: 10.1128/JVI.00556-18
– ident: CIT0045
  doi: 10.1038/s41586-020-2548-6
– ident: CIT0036
  doi: 10.1074/jbc.M114.610428
– ident: CIT0005
  doi: 10.1126/science.abb2507
– ident: CIT0037
  doi: 10.1073/pnas.0306446101
– ident: CIT0046
  doi: 10.1038/s41423-020-00605-4
– ident: CIT0028
  doi: 10.1016/j.cell.2020.12.015
– ident: CIT0008
  doi: 10.1016/j.antiviral.2020.104742
– ident: CIT0027
  doi: 10.1128/JCM.02107-20
SSID ssj0000706414
Score 2.3116934
Snippet Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy....
SourceID doaj
pubmedcentral
crossref
pubmed
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 894
SubjectTerms Ammonium Chloride - pharmacology
Animals
Antibodies, Viral - blood
Antigen-Antibody Reactions
Blotting, Western
Chlorocebus aethiops
Convalescence
COVID-19 - blood
COVID-19 - immunology
Defective Viruses - genetics
Genes, Reporter
Genetic Vectors - immunology
HEK293 Cells
HIV-1 - genetics
Humans
Immunoglobulin G - immunology
Lentivirus - genetics
monomeric infrared fluorescent protein
Mutagenesis, Site-Directed
neutralization
Neutralization Tests - methods
Pandemics
Point Mutation
pseudovirus
reporter
SARS-CoV-2
SARS-CoV-2 - immunology
Spike Glycoprotein, Coronavirus - genetics
Spike Glycoprotein, Coronavirus - immunology
Vero Cells
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT0gI8WZ5aQ5cXey148dxqagqJDhQinqLHD_ESiW7yib8D_4x4zhbJVx64ZjEsiaZieebsecbQt77qsE42UWqDBNUco_rIA8YqhilnfV-LV1ODXz5qi6u5Ofr6nrW6iufCSv0wOXDfVijD0qJCxOTlVIGZxy6eIysmE5G2hL4MDsLpsY1WKOr5fJYsmMYzoMz6SqHhGt-irim4kosnNHI2f8PY-nMLy3PTM6c0Pkj8nBCj7ApUj8m92L7hDwoqTcoFUVPyZ8NIBK8obltPLg2QKYkplNDnv3QQxuHMb9RKjABwWYP2ZsFwKvLzbdLerb7QdewP8Qh7H5vu-EA-Uh7aSYBv3IdRN7nAXyHLh9gh3Qz7LpCDAUj88O2BXeAsiERu2fk6vzT97MLOnVeoL4Ssqea2xRTLpRXPqhgdRJNkjI6o5JDjCKljcIyz4JViDeC5R6HJumCx3DRBPGcnLS7Nr4koBqdYnCCe-kk18H6iiXPdcOaxFgIK3J6VEG9LwQbNZ94S486q7PO6klnK_IxK-p2cObHHm-g1dST1dR3Wc2K2Lma635Mj6TSy6QWdwjwopjCrQgig0wr5IrohZEsZFw-abc_Ry5vg2JhCPrqf7zUa3I_y1kSRG_ISd8N8S1Cpr55N_4dfwFShhHH
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access(OpenAccess)
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELaW5YKEEG_KS3Pg6hLXTmIfECorViskOLAU7S1y_IBKJSlpguBn8I8Zx-6qQSAuHPOSxhnb88145htCnpm8Rj9ZO1rIjFPBDO6DzKKrIotSK2MWQofQwNt3xdlKvLnIL47InlAh_cDdH1270E9q1W3m37_-eIkL_kXKkHuOJg6BdR68vQWbI2TJEWRcIVcXAp31kM2XEP-4OZdog5nY1_L87euJlRrJ_H-jMj0wWNNkygPrdHqT3EiwEpZxHtwiR665Ta7HmBzEUqM75OcSECJuaOgnD7qxELiKaerUsx16aNwwBj5iaSYgCu0hmDkLeHW-fH9OT9qPdAHbnRts-23dDTsIue6xywR8CQUS4QAIcAxdyGwHvxnaLjJGwUgJsW5A7yCeVLjuLlmdvv5wckZTSwZqci56WjLlnQ8V9IWxhVWl57UXwmlZeI3gRQjluMpMZlWBQMQqZvBVL7Q16EdKy--R46Zt3AMCRV16ZzVnRmjBSqtMnnnDyjqrfZZZOyPzvQqqbWTeqFgiNN3rrAo6q5LOZuRVUNTly4E4e7zRdp-qtA7xSya9Z1w6r4QQVkuNiBEd9az0Uig2I-pQzVU_xk18bHJS8X8IcD9OhUsReECfiosZKSeTZCLj9Emz_jySfEsUC33Th_9jUI_ItSBnjBw9Jsd9N7gniKX6-um4On4BFiEaeA
  priority: 102
  providerName: Scholars Portal
– databaseName: Taylor & Francis Open Access
  dbid: 0YH
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9QwDI5guSAhxJvhpRy4dkkmbpochxWrERIcWBbBqUrzgJF221Ef_A_-MU7TjqZIiAPHtonkykn82bE_E_La5hX6ycZnUjGRAbd4DnKHroqShdHWrsHE0MCHj3J7Ce-_5nM2YTelVUYfOiSiiPGsjpvbVN2cEfcGTRoC6Tx6d2t-ihAlR1Bxk9xa47tIn8--bQ9hFlzREjjMtTt_m72wSiN5_x_UpUcGapk8eWSNzu-RuxOMpJuk9_vkhq8fkDspBkdTadFD8mtDERJeZbF_PMW_pZGbOJs68-yHntZ-GAMdqRSTIursaTRrjuLTxebTRXbWfMnWdN_5wTU_d-3Q0ZjbnrpK0OtYEBEvfCj-Qxsz2Wm4Gpo2MUTRkQJiV1PT0XQz4dtH5PL83eezbTa1YMhsLqDPCq6DD7FiXlonnS6CqAKAN0oGg2AFQHuhmWVOSwQeTnOLQwMYZ9FvVE48Jid1U_unhMqqCN4ZwS0Y4IXTNmfB8qJiVWDMuRU5nVVQ7hPTRsknAtNZZ2XUWTnpbEXeRkUdBkei7PFF034vp32HM7kKgQvlgwYAZ5RBhIiOOSuCAs1XRB-ruezHOElITU1K8Q8BnqSlcBBBRLSpBaxIsVgkCxmXX-rdj5HUW6FY6Is--w95npPb8TEFiF6Qk74d_EuETH31atwUvwEhag_l
  priority: 102
  providerName: Taylor & Francis
Title A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter
URI https://www.tandfonline.com/doi/abs/10.1080/22221751.2021.1925163
https://www.ncbi.nlm.nih.gov/pubmed/33929934
https://pubmed.ncbi.nlm.nih.gov/PMC8143625
https://doaj.org/article/2218ff138ef9444da8a14313307f8491
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBabPZSFUvrebNugQ69OpEi2pWMauoRCSul2y_ZkZD3aQOIEx-7_2H_ckWQvcS-FXgx-CMbMWPPNeOYbhN7rtIQ4WdkkE4QlnGrYB6mBUEVkuZJaz7nyqYH152x1yz_dpXdnKO17YULRvi4302q7m1abX6G28rDTs75ObPZlvRTg5AG3z0ZoBAZ6EqKH7TcHL0t5360jyAxcIADv1EeDczoFSJMCCLlAj5jHBpLxgUsKzP1_8ZaeeKdh5eSJK7p-ip50GBIvoqzP0JmtnqPHMQGHY1_RC3S_wIAHt4kfHo9VZbAnJk66sTyHtsGVbUOWI_ZhYoCcDfY-zWA4u1l8vUmW--_JHB-OtjX735u6PWJf2B5HSuCd74bwf3swvEPty9ix27b7OtJD4cD_sKmwOuL4W8LWL9Ht9cdvy1XSzV9IdMp4k-RUOut8u3ymTWZk7ljpOLdKZE4BUuFcWiaJJkZmgDqMpBoedVwZDUGjMOwVOq_2lb1EOCtzZ41iVHPFaW6kTonTNC9J6QgxZoymvQqKQ6TZKGjHXtqrr_DqKzr1jdEHr6iHhz1Ldriwr38Wna3ASiqco0xYJznnRgkFlgNROcmd4JKOkTxVc9GEJImLE00K9g8BXkdTeBChN6cxygdGMpBxeAcMPDB6dwZ99d8r36ALL1zMDb1F503d2neAlppygkbkx2oScg1wXHMxCd_LH_TLFl8
link.rule.ids 230,315,730,783,787,867,888,2109,2228,24330,27514,27936,27937,53804,53806,59471,59472
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagHECqUHkvUPCBa0q8njx8XCqqLbQ90BaVU-T4UVYqySqb9H_wj5mJs6sNUsWBY-JYGmtszzeTmW8Y-2CSEv1k7aI0j2UEwuA9KCy6KnmaaWXMFDSFBk7P0vklfLlKrrZqYSitknxoH4gi-ruaDjcFo9cpcR_RpiGSTsi9m4oDxCgJoor77EGiIKMuBvGP-SbOgls6BQHr4p27Zo_MUs_e_xd36ZaFGmdPbpmjoz32eMCRfBYU_4Tdc9VTthuCcDzUFj1jv2ccMeFNRA3kOS6XEzlxNLTmWXYtr1zXRzpCLSZH2NlysmuW49P57Nt5dFh_j6Z8uXKdrW8XTbfilNwe2krwX1QRQX98OK6hoVR27m-6ugkUUbzngFhUXK94-DXhmufs8ujzxeE8GnowRCaR0EaZUN55KplPjU2tyrwsPYDTeeo1ohUA5aSKTWxVisjDKmHwUw_aGnQccytfsJ2qrtwrxtMy885qKQxoEJlVJom9EVkZlz6OrZ2wg7UKimWg2ijEwGC61llBOisGnU3YJ1LU5mNiyu5f1M11MRw8nCly74XMnVcAYHWuESKiZx5nPgclJkxtq7lo-0CJD11NCvkPAV6GrbARQRLcVBImLBttkpGM45Fq8bNn9c5RLHRGX_-HPO_Zw_nF6Ulxcnz29Q17REMhWvSW7bRN5_YRP7Xlu_6A_AHVlBNV
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgkRASWvFcytMHrl7s2nHsY1moymuFWBbBKXL8gEpLUqUJ_2P_MeM4qRokxIFj4kQaa2zPN-OZbxB6brMS_GTjiVSUE8EsnIPMgauiZG60tXNhYmjgw6lcnYu3X7Mxm3A7pFVGHzokooj-rI6be-PCmBH3AkwaAOksendzdgwQJQNQcRVdyzSctLCk6bfVLswCK1oKJsbanb_9PbFKPXn_H9SlewZqmjy5Z42Wt9DhACPxIun9NrriqzvoZorB4VRadBddLjBAwgsS-8djmC2O3MRk6Myz6Vpc-a4PdKRSTAyos8XRrDkMT2eLT2fkpP5C5niz9Z2rf62bbotjbnvqKoF_xoKIeOGDYQ5NzGTH4aKrm8QQhXsKiHWFzRanmwnf3EPny9efT1ZkaMFAbMZFS3Kmgw-xYl5aJ53OAy-DEN4oGQyAFSG055pa6rQE4OE0s_BpEMZZ8BuV4_fRQVVX_gHCssyDd4YzK4xgudM2o8GyvKRloNS5GToeVVBsEtNGwQYC01FnRdRZMehshl5GRe0-jkTZ_Yu6-V4M-w7-ZCoExpUPWgjhjDKAEMExp3lQQrMZ0vtqLto-ThJSU5OC_0OAo7QUdiLwiDY1FzOUTxbJRMbpSLX-0ZN6KxALfNGH_yHPM3T946tl8f7N6btH6EYcSbGix-igbTr_BNBTWz7t98dvDRQSfg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+real-time+and+high-throughput+neutralization+test+based+on+SARS-CoV-2+pseudovirus+containing+monomeric+infrared+fluorescent+protein+as+reporter&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Wen-Yang+Tsai&rft.au=Lauren+L.+Ching&rft.au=Szu-Chia+Hsieh&rft.au=Marian+E.+Melish&rft.date=2021-01-01&rft.pub=Taylor+%26+Francis+Group&rft.eissn=2222-1751&rft.volume=10&rft.issue=1&rft.spage=894&rft.epage=904&rft_id=info:doi/10.1080%2F22221751.2021.1925163&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_2218ff138ef9444da8a14313307f8491
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon